Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 7 Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Breast Neoplasms 2 Sarcoma 1 Rectal Neoplasms 1 Neoplasm Metastasis 1 Kidney Neoplasms 1 Disease 1 Desmoid Tumors 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Adenocarcinoma 1

Interventions

Gene Expression Profiling 9 Blood Specimen Collection 6 Polymerase Chain Reaction 5 Immunohistochemistry 5 Amplified Fragment Length Polymorphism Analysis 5 Surveys and Questionnaires 3 Sunitinib 3 Reverse Transcriptase Polymerase Chain Reaction 3 Flow Cytometry 3 Biopsy 3 Surgical Procedures, Operative 2 Radiotherapy 2 Radiosurgery 2 Patient Reported Outcome Measures 2 Observation 2 Nivolumab 2 Microarray Analysis 2 Immunotherapy 2 Genetic Testing 2 Drug Therapy 2 DNA Methylation 2 Cytogenetic Analysis 2 tremelimumab 1 pembrolizumab 1 durvalumab 1 atezolizumab 1 aldesleukin 1 X-Rays 1 Watchful Waiting 1 Tomography, Optical Coherence 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Kidney Neoplasms × Cryosurgery × Clear all

NCT01117779 2024-01-19

TRACE

Boston Scientific Corporation

246 enrolled 18 charts

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡